Advertisement
Screener

TELA Bio, Inc. (TELA) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

TELA Bio, Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • TELA Bio, Inc. return tang equity for the quarter ending 2026-06-30 was 259.54%, a change of 703.43% year-over-year.
  • TELA Bio, Inc. return tang equity for the quarter ending 2026-03-31 was 766.01%, a change of 1005.72% year-over-year.
  • TELA Bio, Inc. return tang equity for the quarter ending 2025-12-31 was -615.10%, a change of -482.12% year-over-year.
  • TELA Bio, Inc. return tang equity for the quarter ending 2025-09-30 was -2504.69%, a 478.33% decline year-over-year.
  • TELA Bio, Inc. return tang equity for fiscal 2025 was -615.10%, a change of -482.12% from fiscal 2024.
  • TELA Bio, Inc. return tang equity for fiscal 2024 was -132.97%, a change of 114.18% from fiscal 2023.
  • TELA Bio, Inc. return tang equity for fiscal 2023 was -247.15%, a change of 62.51% from fiscal 2022.
  • TELA Bio, Inc. return tang equity for fiscal 2022 was -309.65%, a change of -144.09% from fiscal 2021.
Available history
2017-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30259.54%-$41.18M-$15.87M
2026-03-31766.01%-$39.84M-$5.2M
2025-12-31-615.10%-$38.83M$6.31M
2025-09-30-2504.69%-$39M$1.56M
2025-06-30-443.89%-$40.77M$9.18M
2025-03-31-239.72%-$43.44M$18.12M
2024-12-31-132.97%-$37.84M$28.46M
2024-09-30662.04%-$41.52M-$6.27M
2024-06-30-1467.18%-$42.11M$2.87M
2024-03-31-280.16%-$40.3M$14.38M
2023-12-31-247.15%-$46.66M$18.88M
2023-09-30-143.21%-$43.75M$30.55M
2023-06-30-108.76%-$43.51M$40.01M
2023-03-31-1447.34%-$45.46M$3.14M
2022-12-31-309.65%-$44.3M$14.31M
2022-09-30-184.27%-$42.94M$23.3M
2022-06-302625.68%-$40.49M-$1.54M
2022-03-31-358.66%-$36M$10.04M
2021-12-31-165.57%-$33.28M$20.1M
2021-09-30-117.01%-$32.45M$27.73M
2021-06-30-91.19%-$31.88M$34.97M
2021-03-31-71.26%-$29.71M$41.69M
2020-12-31-58.73%-$28.79M$49.03M
2020-09-30-48.88%-$27.54M$56.33M
2020-06-30-38.64%-$24.5M$63.4M
2020-03-31-97.74%-$23.68M$24.23M
2019-12-31-72.43%-$22.43M$30.96M
2019-09-3014.52%-$23.28M-$160.4M
2019-06-3013.93%-$21.42M-$153.75M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-615.10%-$38.83M$6.31M
2024-12-31-132.97%-$37.84M$28.46M
2023-12-31-247.15%-$46.66M$18.88M
2022-12-31-309.65%-$44.3M$14.31M
2021-12-31-165.57%-$33.28M$20.1M
2020-12-31-58.73%-$28.79M$49.03M
2019-12-31-72.43%-$22.43M$30.96M
2018-12-3115.30%-$21.09M-$137.86M
2017-12-3119.72%-$21.33M-$108.17M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
InspireMD, Inc. (NSPR)$0.033B